Ross Todd
Ross Todd is the Editor/columnist for the Am Law Litigation Daily. He writes about litigation of all sorts. Previously, Ross was the Bureau Chief of The Recorder, ALM's California affiliate. Contact Ross at [email protected]. On Twitter: @Ross_Todd.
March 11, 2022 | Litigation Daily
Litigator of the Week Runners-Up and Shout OutsOur first Litigator of the Week runners-up this week at Winston & Strawn scored a major appellate reversal for Cox Communications. You might remember…
By Ross Todd
6 minute read
March 10, 2022 | Litigation Daily
Miami Litigator Peter Prieto Describes What He Sees on the Horizon in Multidistrict LitigationPrieto, the head of commercial and class action litigation at Miami boutique Podhurst Orseck, is set to moderate a panel of MDL judges at The Miami Law Class Action and Complex Litigation Forum on Friday.
By Ross Todd
7 minute read
March 09, 2022 | Litigation Daily
The 'Go BIG' Method for Closing ArgumentsRobert Vaughan of Kim Vaughan Lerner uses the "Go BIG" acronym to describe his way of starting closings with a "grabber" and then incorporating the burden of proof, jury instructions and the grounds for getting a jury to go his way.
By Ross Todd
5 minute read
March 08, 2022 | Litigation Daily
Miami-Dade Administrative Judge Jennifer Bailey Says More Remote Participation By Unrepresented Litigants 'Means Better Justice'"The quality of justice, I would propose to you, may be significantly better on remote than it was in the good old days of the cattle calls," said Bailey during a forum sponsored by the Legal Services Corporation.
By Ross Todd
5 minute read
March 07, 2022 | Litigation Daily
Litigation Leaders: Desmarais LLP Founder John Desmarais on the Firm's Early Focus on Trial Strategy"While patent cases are complex technically and legally, they must be presented to everyday people on juries in terms that make sense to them."
By Ross Todd
12 minute read
March 04, 2022 | Litigation Daily
Litigators of the Week: Quinn Emanuel Gets a Vital Win on Gene-Editing Patents at the PTABRay Nimrod, Matt Robson, and Zach Summers of Quinn Emanuel persuaded the Patent Trial and Appeal Board that their client, the Broad Institute, invented the use of the gene-editing technology CRISPR-Cas9 in plants and animals before two scientists who won the Nobel Prize in 2020 for work on it.
By Ross Todd
9 minute read
March 04, 2022 | Litigation Daily
Litigator of the Week Runners-Up and Shout OutsOur first runners-up this week are the plaintiffs' teams who pursued claims against Allianz Global Investors tied to losses racked up by its Structured…
By Ross Todd
5 minute read
March 03, 2022 | Litigation Daily
Trial Lawyers Have a Reputation for Being Generalists. What If Going to Trial Is Their Specialty?"I actually think the act of taking a case to trial, preparing it for trial, and executing a trial is itself a specialty," says Karen Dunn of Paul Weiss.
By Ross Todd
5 minute read
March 02, 2022 | Litigation Daily
Gibson Dunn Litigation Co-Chair Veronica Moyé: 'You Can't Let the Risk of Losing Drive Your Whole Strategy'Moyé, who went in-house as the general counsel of a healthcare client for about three years in the mid-2000s, said there are long-term consequences for continuously settling cases for less than defense costs.
By Ross Todd
5 minute read
March 01, 2022 | Litigation Daily
As Firm Financials for 2021 Start Flowing In, A Couple of Observations on Litigation Micro-TrendsEven though the transactional sides of large law firms seem to be the primary drivers of record profits across the industry, litigation-heavy firms have so far posted strong returns — especially Texas firms busy handling the litigation fallout from Winter Storm Uri.
By Ross Todd
4 minute read
